| http://www.w3.org/ns/prov#value | - In August of 2004, regulatory officials in several European markets including Germany, Sweden, Denmark, Finland, Belgium, Hungary, Portugal, and Romania approved Gemzar in combination with carboplatin for the treatment of recurrent epithelial ovarian cancer.
|
